Cerebrolysin and Recovery after Stroke (CARS): A randomized, placebo-controlled, double-blind, multicenter, phase ii clinical study

被引：0
|
作者：
Muresanu, D. [1 ]
Heiss, W. D. [2 ]
Bajenaru, O. [3 ]
Popescu, C. D. [4 ]
Vester, J. [5 ]
Guekht, A. [6 ]
机构：
[1] Univ Med & Pharm Iuliu Hatieganu, Neurosci, Cluj Napoca, Romania
[2] Max Planck Inst Neurol Res, Neurol, D-50931 Cologne, Germany
[3] Carol Davila Univ Med & Pharm, Neurol, Bucharest, Romania
[4] Carol Davila Univ Med & Pharm, Neurol, Iasi, Romania
[5] IDV Data Anal & Study Planning, Biometry & Clin Res, Krailing, Germany
[6] Russian State Med Univ Moscow City Hosp, Neurol & Neurosurg, Moscow, Russia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2015年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ESOC-1155
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [21] Ropinirole in the treatment of motor deficits after stroke: A randomized, placebo-controlled, double-blind study
    Cramer, Steven C.
    Dobkin, Bruce H.
    Noser, Elizabeth A.
    Rodriguez, Rachelle W.
    Enney, Lori A.
    STROKE, 2008, 39 (02) : 542 - 542
  • [22] Randomized clinical trial: rikkunshito in the treatment of functional dyspepsiaa multicenter, double-blind, randomized, placebo-controlled study
    Suzuki, H.
    Matsuzaki, J.
    Fukushima, Y.
    Suzaki, F.
    Kasugai, K.
    Nishizawa, T.
    Naito, Y.
    Hayakawa, T.
    Kamiya, T.
    Andoh, T.
    Yoshida, H.
    Tokura, Y.
    Nagata, H.
    Kobayakawa, M.
    Mori, M.
    Kato, K.
    Hosoda, H.
    Takebayashi, T.
    Miura, S.
    Uemura, N.
    Joh, T.
    Hibi, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07): : 950 - 961
  • [23] A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial of fruquintinib in patients with metastatic colorectal cancer (mCRC)
    Li, J.
    Xu, R.
    Bai, Y.
    Xu, J.
    Liu, T.
    Shen, L.
    Wang, L.
    Pan, H.
    Fan, S.
    Hua, Y.
    Su, W.
    Hugg, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S366 - S366
  • [24] FLAME: A Multicenter Randomized Double-Blind Placebo-Controlled Trial with Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke
    Chollet, Francois
    Tardy, Jean
    Albucher, Jean Francois
    Arnaud, Catherine
    Berard, Emilie
    Bejot, Yannick
    Lamy, Catherine
    Jaillard, Assia
    Deltour, Sandrine
    Niclot, Philippe
    Guillon, Benoit
    Moulin, Thierry
    Marque, Phillipe
    Pariente, Jeremie
    Thalamas, Claire
    Loubinoux, Isabella
    NEUROLOGY, 2011, 76 (09) : A666 - A666
  • [25] Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial
    Liu, X.
    Xia, J.
    Wang, L.
    Song, Y.
    Yang, J.
    Yan, Y.
    Ren, H.
    Zhao, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (05) : 569 - 575
  • [26] Double-Blind, Placebo-Controlled, Clinical study to Investigate the Safety and Efficacy of NeuroAid on Motor Recovery after Ischemic Stroke
    Pakdaman, H.
    CEREBROVASCULAR DISEASES, 2013, 35 : 299 - 299
  • [27] The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial
    Asadollahi, Marjan
    Ramezani, Mahtab
    Khanmoradi, Ziba
    Karimialavijeh, Ehsan
    CLINICAL REHABILITATION, 2018, 32 (08) : 1069 - 1075
  • [28] Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
    Levin, B
    Thompson, JLP
    Levy, G
    Mitsumoto, H
    Kaufmann, P
    NEUROLOGY, 2006, 66 (11) : 1786 - 1786
  • [29] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    NEUROLOGY, 2006, 66 (01) : 88 - 92
  • [30] The Effect of Lithium in Post-Stroke Motor Recovery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
    Mohammadianinejad, Seyed Ehsan
    Majdinasab, Nastaran
    Sajedi, Seyed Aidin
    Abdollahi, Fahimeh
    Moqaddam, Mehdi Masoudi
    Sadr, Fatemeh
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (03) : 73 - 78
12345